Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926692 · ClinicalTrials.gov registry record
Investigations Regarding B-cell Subsets in Humans
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 249
- Enrollment target
NCT00926692: Completed study, sponsored by Northwell Health.
NCT00926692 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926692 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
Study Summary
The aim of this research is to define the human equivalent of mouse B1 cells.
Primary Outcome
an equivalent cell type was isolated in humans
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-07 |
What the finished NCT00926692 record still lists
NCT00926692 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00926692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00926692 about?
NCT00926692 is a clinical study titled "Investigations Regarding B-cell Subsets in Humans". The aim of this research is to define the human equivalent of mouse B1 cells.
What is the current status of trial NCT00926692?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2009-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00926692?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00926692?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia